Rating7 Jun 2025, 12:21 pm
AstraZeneca Pharma India Ltd Receives ESG Score of 64.9 for FY 2023-24 from SES ESG Research
AI Summary
AstraZeneca Pharma India Ltd has been assigned an Environmental, Social, and Governance (ESG) Score (Adjusted) of 64.9, which corresponds to a Grade B, by SES ESG Research Private Limited. This score is based on publicly available information pertaining to FY 2023-24. The company did not engage SES for this rating, and SES has independently prepared the report. This disclosure is in compliance with Regulation 30 of SEBI Listing Regulations and the SEBI Circular SEBI/HO/CFD/CFD-PoD- 1/P/CIR/2023/123 dated July 13, 2023.
Key Highlights
- AstraZeneca Pharma India Ltd received an ESG Score (Adjusted) of 64.9 (Grade B) from SES ESG Research
- The score is based on publicly available information pertaining to FY 2023-24
- The company did not engage SES for this rating
- SES has independently prepared the report
- This disclosure is in compliance with SEBI regulations and circulars